Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00353886 · ClinicalTrials.gov registry record
Study of Antiepileptic Drug Effects on Child Development
A clinical trial of Epilepsy, sponsored by Augusta University.
- Completed
- Registry status
- 81
- Enrollment target
- 10
- Study locations
NCT00353886: Completed study of Epilepsy, sponsored by Augusta University.
NCT00353886 is a study of Epilepsy that has completed, run by Augusta University. The registered enrollment target is 81 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (91% lower). The trial reports 10 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00353886, a study of Epilepsy, has completed, sponsored by Augusta University.
- COMPLETED
- Registry status
- 81 participants
- Enrollment target
- 10
- Study locations
Study Summary
The specific aim of this study is to determine if in utero exposure produces differential antiepileptic drug (AED) effects on subsequent cognitive abilities and behavioral abnormalities in children
Conditions Studied
Interventions
- PROCEDURE TONI-3
- PROCEDURE WRAT-3
- PROCEDURE Connor's Rating Scales PRS & TRS
- PROCEDURE Peabody Picture Vocabulary Test
- PROCEDURE Children's Memory Scale
Study Locations (10)
Georgia
- Emory University School of Medicine - Atlanta
- Medical College of Georgia - Augusta
California
- University of Southern California - Los Angeles
District of Columbia
- Georgetown University - Washington D.C.
Florida
- University of Florida - Gainesville
Massachusetts
- Boston University - Boston
Michigan
- Henry Ford Hospital - Detroit
Minnesota
- Minnesota Epilepsy Group - Saint Paul
Ohio
- Case Western Reserve University - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2002-09 |
| Est. Completion | 2007-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00353886
The ClinicalTrials.gov registry entry for NCT00353886 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (91% lower). The listed sponsor is Augusta University, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 5 interventions - of which TONI-3 is the first listed.
NCT00353886 reports 10 study locations spanning 9 distinct geographic areas - top geographies include Georgia, California, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT00353886 about?
NCT00353886 is a clinical study titled "Study of Antiepileptic Drug Effects on Child Development". The specific aim of this study is to determine if in utero exposure produces differential antiepileptic drug (AED) effects on subsequent cognitive abilities and behavioral abnormalities in children
What is the current status of trial NCT00353886?
This trial is currently completed. The enrollment target is 81 participants. The study started on 2002-09. Estimated completion is 2007-06.
What conditions does trial NCT00353886 study?
This clinical trial studies the following conditions: Epilepsy.
What interventions are being tested in trial NCT00353886?
The interventions under investigation include: TONI-3 (PROCEDURE), WRAT-3 (PROCEDURE), Connor's Rating Scales PRS & TRS (PROCEDURE), Peabody Picture Vocabulary Test (PROCEDURE), Children's Memory Scale (PROCEDURE).
Who is sponsoring clinical trial NCT00353886?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00353886 being conducted?
This trial has 10 study locations across California, District of Columbia, Florida, Georgia, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
RECRUITING
-
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
RECRUITING
-
SeizEAR Safety Study
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Tumor Related Epilepsy
RECRUITING
-
Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00093964 · 81 participants · Phase 2
Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)
- NCT00198107 · 81 participants · Phase 3
Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism
- NCT00243906 · 81 participants · Phase 2
Interventional Management of Stroke (IMS) II Study
- NCT00419276 · 81 participants · NA
Effect of Ambulatory Continuous Femoral Nerve Blocks on Readiness-for-Discharge Following Total Knee Replacement
Similar registry start date
- NCT06397781 · started 2031-01-01 · Phase 4
Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients
- NCT03849963 · started 2030-07-30
Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain
- NCT07599852 · started 2029-05-01 · NA
MEDBRIDGE-Guided NCM/CHW Post-Discharge Support for High-Risk T2D Patients
- NCT07456150 · started 2029-01-01 · Phase 1
Personalizing Veteran Pain Care: Adapting Coaching Interventions to Support Maintenance of Self-Care
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.